EVOGLIPTIN TARTRATE

EVOGLIPTIN TARTRATE: Drug: Evogliptin Tartrate

Use: Evogliptin Tartrate is a medication used to treat type 2 diabetes mellitus. It is prescribed to help control blood sugar levels in patients who have not achieved adequate glycemic control with diet and exercise alone.

Mechanism of Action: Evogliptin Tartrate belongs to a class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors. It works by inhibiting the enzyme DPP-4, which breaks down incretin hormones. By inhibiting this enzyme, Evogliptin Tartrate increases the levels of active incretin hormones, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). These hormones stimulate glucose-dependent insulin secretion, decrease glucagon secretion, and slow gastric emptying, all of which help to reduce blood sugar levels.

Dose: The usual recommended dose of Evogliptin Tartrate is 5 mg taken orally once daily. However, the dose may vary based on individual patient factors and should be determined by a healthcare professional.

Side Effects: Common side effects of Evogliptin Tartrate may include headaches, upper respiratory tract infections, urinary tract infections, joint pain, and back pain. Rarely, it may cause pancreatitis, allergic reactions, or severe joint pain. It is important to talk to a doctor if any unusual or severe side effects are experienced.

Please note that this information is not exhaustive and should not replace the advice of a healthcare professional. Always consult a doctor or pharmacist for personalized guidance based on your specific health condition and the medications you are taking.